Building a Patient-centric Digital Ecosystem for Cell and Gene Therapies

About this Content

Cell and Gene Therapy (CGT) continues to be the fastest growing area of therapeutics, with several new therapies available to patients and hundreds more in development. To successfully deliver these innovative therapies to patients, cell and gene therapy companies need to design a digital ecosystem that ensures seamless connectivity among all the stakeholders while reducing costs and improving patient experience.

A well-connected digital ecosystem will break down traditional silos between stakeholders for efficient tracking of end-to-end patient and product journey. Integrated systems and data flows also work to serve the needs of different stakeholders by providing timely alerts/notifications regarding patient and product status, respond to patient and caregiver enquiries, and capture data within the patient’s record for long-term follow-up purposes.

In this whitepaper, you will learn about:

• CGT organizational units and their functions
• Key processes across the CGT value chain
• Electronic systems required to support CGTs
• IT considerations for designing a robust CGT digital ecosystem

Download this whitepaper to gain valuable insights on how CGT companies can build digital capabilities for end-to-end supply chain visibility and orchestration while reducing costs and improving patient experience.